Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.0821
Delayed Data
As of 9:40am ET
 -0.0011 / -1.32%
Today’s Change
0.07
Today|||52-Week Range
0.71
-80.47%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.08
Today’s open0.08
Day’s range0.08 - 0.08
Volume63,184
Average volume (3 months)8,436,577
Market cap$19.8M
Dividend yield--
Data as of 9:40am ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+22.67%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.57

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...+0.02+1.96%
CERUCerulean Pharma Inc+0.03+4.12%
HEBHemispherx Biopharma...+0.09+11.31%
OCLSOculus Innovative Sc...-0.03-0.62%
Data as of 9:55am ET, 12/05/2016

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
CFO, Principal Accounting Officer &
SVP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs